nodes	percent_of_prediction	percent_of_DWPC	metapath
Vemurafenib—CYP1A2—Citalopram—alcohol dependence	0.136	0.324	CbGbCtD
Vemurafenib—CYP2D6—Citalopram—alcohol dependence	0.112	0.267	CbGbCtD
Vemurafenib—CYP3A4—Disulfiram—alcohol dependence	0.1	0.238	CbGbCtD
Vemurafenib—CYP3A4—Citalopram—alcohol dependence	0.0714	0.17	CbGbCtD
Vemurafenib—ORM1—bile—alcohol dependence	0.0162	0.131	CbGeAlD
Vemurafenib—Common wart—Citalopram—alcohol dependence	0.0157	0.061	CcSEcCtD
Vemurafenib—ORM1—saliva—alcohol dependence	0.0106	0.0856	CbGeAlD
Vemurafenib—Rash papular—Naltrexone—alcohol dependence	0.00963	0.0375	CcSEcCtD
Vemurafenib—Sunburn—Citalopram—alcohol dependence	0.00753	0.0293	CcSEcCtD
Vemurafenib—Skin papilloma—Citalopram—alcohol dependence	0.00697	0.0272	CcSEcCtD
Vemurafenib—Etoricoxib—CYP2E1—alcohol dependence	0.00683	1	CrCbGaD
Vemurafenib—VIIth nerve paralysis—Citalopram—alcohol dependence	0.00554	0.0216	CcSEcCtD
Vemurafenib—Hepatotoxicity—Naltrexone—alcohol dependence	0.00465	0.0181	CcSEcCtD
Vemurafenib—Rigors—Naltrexone—alcohol dependence	0.00439	0.0171	CcSEcCtD
Vemurafenib—Gamma-glutamyltransferase increased—Naltrexone—alcohol dependence	0.00436	0.017	CcSEcCtD
Vemurafenib—Neuropathy peripheral—Disulfiram—alcohol dependence	0.00422	0.0164	CcSEcCtD
Vemurafenib—RAF1—brainstem—alcohol dependence	0.00379	0.0306	CbGeAlD
Vemurafenib—Polyp—Citalopram—alcohol dependence	0.00374	0.0146	CcSEcCtD
Vemurafenib—BRAF—blood—alcohol dependence	0.00367	0.0297	CbGeAlD
Vemurafenib—RAF1—forebrain—alcohol dependence	0.00365	0.0296	CbGeAlD
Vemurafenib—BRAF—midbrain—alcohol dependence	0.00362	0.0293	CbGeAlD
Vemurafenib—Folliculitis—Citalopram—alcohol dependence	0.00362	0.0141	CcSEcCtD
Vemurafenib—Electrocardiogram QT prolonged—Citalopram—alcohol dependence	0.00354	0.0138	CcSEcCtD
Vemurafenib—Rash maculo-papular—Acamprosate—alcohol dependence	0.00345	0.0134	CcSEcCtD
Vemurafenib—Cyst—Citalopram—alcohol dependence	0.0034	0.0132	CcSEcCtD
Vemurafenib—RAF1—adrenal cortex—alcohol dependence	0.00339	0.0274	CbGeAlD
Vemurafenib—Paralysis—Citalopram—alcohol dependence	0.00327	0.0127	CcSEcCtD
Vemurafenib—RAF1—cardiovascular system—alcohol dependence	0.00309	0.025	CbGeAlD
Vemurafenib—BRAF—testis—alcohol dependence	0.00303	0.0245	CbGeAlD
Vemurafenib—RAF1—pancreas—alcohol dependence	0.003	0.0243	CbGeAlD
Vemurafenib—BRAF—liver—alcohol dependence	0.00287	0.0232	CbGeAlD
Vemurafenib—Arthritis—Acamprosate—alcohol dependence	0.00283	0.011	CcSEcCtD
Vemurafenib—RAF1—gonad—alcohol dependence	0.0028	0.0227	CbGeAlD
Vemurafenib—BRAF—cerebellum—alcohol dependence	0.0028	0.0227	CbGeAlD
Vemurafenib—Rigors—Citalopram—alcohol dependence	0.00278	0.0108	CcSEcCtD
Vemurafenib—Gamma-glutamyltransferase increased—Citalopram—alcohol dependence	0.00276	0.0108	CcSEcCtD
Vemurafenib—Atrial fibrillation—Naltrexone—alcohol dependence	0.00275	0.0107	CcSEcCtD
Vemurafenib—Arthritis—Naltrexone—alcohol dependence	0.00268	0.0104	CcSEcCtD
Vemurafenib—Pain in extremity—Naltrexone—alcohol dependence	0.0026	0.0101	CcSEcCtD
Vemurafenib—RAF1—digestive system—alcohol dependence	0.00256	0.0207	CbGeAlD
Vemurafenib—Dry skin—Acamprosate—alcohol dependence	0.00252	0.00983	CcSEcCtD
Vemurafenib—RAF1—blood—alcohol dependence	0.00244	0.0198	CbGeAlD
Vemurafenib—RAF1—midbrain—alcohol dependence	0.00241	0.0195	CbGeAlD
Vemurafenib—Fatigue—Disulfiram—alcohol dependence	0.00237	0.00922	CcSEcCtD
Vemurafenib—Eosinophilia—Acamprosate—alcohol dependence	0.00236	0.00917	CcSEcCtD
Vemurafenib—Musculoskeletal pain—Citalopram—alcohol dependence	0.0023	0.00896	CcSEcCtD
Vemurafenib—BRAF—brain—alcohol dependence	0.00228	0.0184	CbGeAlD
Vemurafenib—Photosensitivity reaction—Acamprosate—alcohol dependence	0.00217	0.00846	CcSEcCtD
Vemurafenib—Weight decreased—Acamprosate—alcohol dependence	0.00215	0.00838	CcSEcCtD
Vemurafenib—RAF1—endocrine gland—alcohol dependence	0.00212	0.0171	CbGeAlD
Vemurafenib—Rash maculo-papular—Citalopram—alcohol dependence	0.00207	0.00805	CcSEcCtD
Vemurafenib—Neoplasm—Citalopram—alcohol dependence	0.00206	0.008	CcSEcCtD
Vemurafenib—Weight decreased—Naltrexone—alcohol dependence	0.00204	0.00793	CcSEcCtD
Vemurafenib—RAF1—testis—alcohol dependence	0.00202	0.0163	CbGeAlD
Vemurafenib—Infestation—Naltrexone—alcohol dependence	0.00201	0.00782	CcSEcCtD
Vemurafenib—Infestation NOS—Naltrexone—alcohol dependence	0.00201	0.00782	CcSEcCtD
Vemurafenib—RAF1—nervous system—alcohol dependence	0.00198	0.016	CbGeAlD
Vemurafenib—Asthenia—Disulfiram—alcohol dependence	0.00197	0.00767	CcSEcCtD
Vemurafenib—RAF1—liver—alcohol dependence	0.00191	0.0155	CbGeAlD
Vemurafenib—RAF1—central nervous system—alcohol dependence	0.00191	0.0154	CbGeAlD
Vemurafenib—Oedema peripheral—Acamprosate—alcohol dependence	0.00188	0.0073	CcSEcCtD
Vemurafenib—RAF1—cerebellum—alcohol dependence	0.00187	0.0151	CbGeAlD
Vemurafenib—Dizziness—Disulfiram—alcohol dependence	0.00182	0.00707	CcSEcCtD
Vemurafenib—Connective tissue disorder—Naltrexone—alcohol dependence	0.00177	0.00689	CcSEcCtD
Vemurafenib—Atrial fibrillation—Citalopram—alcohol dependence	0.00174	0.00678	CcSEcCtD
Vemurafenib—Rash—Disulfiram—alcohol dependence	0.00173	0.00674	CcSEcCtD
Vemurafenib—Headache—Disulfiram—alcohol dependence	0.00172	0.0067	CcSEcCtD
Vemurafenib—Chills—Acamprosate—alcohol dependence	0.00171	0.00665	CcSEcCtD
Vemurafenib—Arthritis—Citalopram—alcohol dependence	0.0017	0.00661	CcSEcCtD
Vemurafenib—ABCC1—adrenal cortex—alcohol dependence	0.00169	0.0137	CbGeAlD
Vemurafenib—ORM1—blood—alcohol dependence	0.00169	0.0136	CbGeAlD
Vemurafenib—Eye disorder—Naltrexone—alcohol dependence	0.00168	0.00656	CcSEcCtD
Vemurafenib—Alopecia—Acamprosate—alcohol dependence	0.00168	0.00655	CcSEcCtD
Vemurafenib—Cardiac disorder—Naltrexone—alcohol dependence	0.00167	0.00651	CcSEcCtD
Vemurafenib—Malnutrition—Acamprosate—alcohol dependence	0.00166	0.00646	CcSEcCtD
Vemurafenib—Pain in extremity—Citalopram—alcohol dependence	0.00165	0.00643	CcSEcCtD
Vemurafenib—Angiopathy—Naltrexone—alcohol dependence	0.00163	0.00637	CcSEcCtD
Vemurafenib—Mediastinal disorder—Naltrexone—alcohol dependence	0.00162	0.00632	CcSEcCtD
Vemurafenib—Dysgeusia—Acamprosate—alcohol dependence	0.00162	0.00632	CcSEcCtD
Vemurafenib—Chills—Naltrexone—alcohol dependence	0.00162	0.0063	CcSEcCtD
Vemurafenib—Back pain—Acamprosate—alcohol dependence	0.0016	0.00624	CcSEcCtD
Vemurafenib—Alopecia—Naltrexone—alcohol dependence	0.00159	0.0062	CcSEcCtD
Vemurafenib—Malnutrition—Naltrexone—alcohol dependence	0.00157	0.00611	CcSEcCtD
Vemurafenib—Dysgeusia—Naltrexone—alcohol dependence	0.00154	0.00598	CcSEcCtD
Vemurafenib—Back pain—Naltrexone—alcohol dependence	0.00152	0.00591	CcSEcCtD
Vemurafenib—RAF1—brain—alcohol dependence	0.00152	0.0123	CbGeAlD
Vemurafenib—Dry skin—Citalopram—alcohol dependence	0.00151	0.00589	CcSEcCtD
Vemurafenib—Toxic epidermal necrolysis—Citalopram—alcohol dependence	0.00149	0.00579	CcSEcCtD
Vemurafenib—ORM1—endocrine gland—alcohol dependence	0.00146	0.0118	CbGeAlD
Vemurafenib—Cough—Acamprosate—alcohol dependence	0.00145	0.00563	CcSEcCtD
Vemurafenib—Eosinophilia—Citalopram—alcohol dependence	0.00141	0.0055	CcSEcCtD
Vemurafenib—Myalgia—Acamprosate—alcohol dependence	0.00141	0.0055	CcSEcCtD
Vemurafenib—Arthralgia—Acamprosate—alcohol dependence	0.00141	0.0055	CcSEcCtD
Vemurafenib—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.0014	0.00546	CcSEcCtD
Vemurafenib—ABCG2—adrenal cortex—alcohol dependence	0.0014	0.0113	CbGeAlD
Vemurafenib—ORM1—nervous system—alcohol dependence	0.00137	0.0111	CbGeAlD
Vemurafenib—Cough—Naltrexone—alcohol dependence	0.00137	0.00533	CcSEcCtD
Vemurafenib—Anaphylactic shock—Acamprosate—alcohol dependence	0.00135	0.00527	CcSEcCtD
Vemurafenib—Infection—Acamprosate—alcohol dependence	0.00134	0.00523	CcSEcCtD
Vemurafenib—Arthralgia—Naltrexone—alcohol dependence	0.00134	0.0052	CcSEcCtD
Vemurafenib—Myalgia—Naltrexone—alcohol dependence	0.00134	0.0052	CcSEcCtD
Vemurafenib—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.00133	0.00516	CcSEcCtD
Vemurafenib—ORM1—liver—alcohol dependence	0.00132	0.0107	CbGeAlD
Vemurafenib—ORM1—central nervous system—alcohol dependence	0.00132	0.0107	CbGeAlD
Vemurafenib—Skin disorder—Acamprosate—alcohol dependence	0.00131	0.00512	CcSEcCtD
Vemurafenib—Photosensitivity reaction—Citalopram—alcohol dependence	0.0013	0.00507	CcSEcCtD
Vemurafenib—Weight decreased—Citalopram—alcohol dependence	0.00129	0.00502	CcSEcCtD
Vemurafenib—Anaphylactic shock—Naltrexone—alcohol dependence	0.00128	0.00498	CcSEcCtD
Vemurafenib—Infection—Naltrexone—alcohol dependence	0.00127	0.00495	CcSEcCtD
Vemurafenib—Infestation NOS—Citalopram—alcohol dependence	0.00127	0.00495	CcSEcCtD
Vemurafenib—Infestation—Citalopram—alcohol dependence	0.00127	0.00495	CcSEcCtD
Vemurafenib—Hypotension—Acamprosate—alcohol dependence	0.00126	0.00492	CcSEcCtD
Vemurafenib—Stevens-Johnson syndrome—Citalopram—alcohol dependence	0.00126	0.00491	CcSEcCtD
Vemurafenib—Nervous system disorder—Naltrexone—alcohol dependence	0.00126	0.00489	CcSEcCtD
Vemurafenib—Neuropathy peripheral—Citalopram—alcohol dependence	0.00125	0.00485	CcSEcCtD
Vemurafenib—Skin disorder—Naltrexone—alcohol dependence	0.00124	0.00484	CcSEcCtD
Vemurafenib—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.00123	0.0048	CcSEcCtD
Vemurafenib—ALB—testis—alcohol dependence	0.00122	0.0099	CbGeAlD
Vemurafenib—ABCC1—blood—alcohol dependence	0.00122	0.00988	CbGeAlD
Vemurafenib—Decreased appetite—Acamprosate—alcohol dependence	0.00118	0.00458	CcSEcCtD
Vemurafenib—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.00117	0.00455	CcSEcCtD
Vemurafenib—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.00117	0.00454	CcSEcCtD
Vemurafenib—Constipation—Acamprosate—alcohol dependence	0.00116	0.00451	CcSEcCtD
Vemurafenib—ALB—liver—alcohol dependence	0.00116	0.00936	CbGeAlD
Vemurafenib—Oedema peripheral—Citalopram—alcohol dependence	0.00112	0.00438	CcSEcCtD
Vemurafenib—Connective tissue disorder—Citalopram—alcohol dependence	0.00112	0.00437	CcSEcCtD
Vemurafenib—Decreased appetite—Naltrexone—alcohol dependence	0.00111	0.00433	CcSEcCtD
Vemurafenib—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.0011	0.0043	CcSEcCtD
Vemurafenib—Fatigue—Naltrexone—alcohol dependence	0.0011	0.0043	CcSEcCtD
Vemurafenib—Constipation—Naltrexone—alcohol dependence	0.00109	0.00426	CcSEcCtD
Vemurafenib—Erythema multiforme—Citalopram—alcohol dependence	0.00108	0.0042	CcSEcCtD
Vemurafenib—CYP2D6—brainstem—alcohol dependence	0.00107	0.00868	CbGeAlD
Vemurafenib—Body temperature increased—Acamprosate—alcohol dependence	0.00107	0.00416	CcSEcCtD
Vemurafenib—Eye disorder—Citalopram—alcohol dependence	0.00107	0.00415	CcSEcCtD
Vemurafenib—Cardiac disorder—Citalopram—alcohol dependence	0.00106	0.00413	CcSEcCtD
Vemurafenib—CYP2D6—forebrain—alcohol dependence	0.00104	0.00838	CbGeAlD
Vemurafenib—Angiopathy—Citalopram—alcohol dependence	0.00104	0.00403	CcSEcCtD
Vemurafenib—Mediastinal disorder—Citalopram—alcohol dependence	0.00103	0.00401	CcSEcCtD
Vemurafenib—Chills—Citalopram—alcohol dependence	0.00102	0.00399	CcSEcCtD
Vemurafenib—CYP1A2—digestive system—alcohol dependence	0.00102	0.00826	CbGeAlD
Vemurafenib—Body temperature increased—Naltrexone—alcohol dependence	0.00101	0.00394	CcSEcCtD
Vemurafenib—ABCG2—blood—alcohol dependence	0.00101	0.00818	CbGeAlD
Vemurafenib—ABCC1—testis—alcohol dependence	0.00101	0.00817	CbGeAlD
Vemurafenib—Alopecia—Citalopram—alcohol dependence	0.00101	0.00393	CcSEcCtD
Vemurafenib—ABCG2—midbrain—alcohol dependence	0.000998	0.00807	CbGeAlD
Vemurafenib—Hypersensitivity—Acamprosate—alcohol dependence	0.000997	0.00388	CcSEcCtD
Vemurafenib—Erythema—Citalopram—alcohol dependence	0.000994	0.00387	CcSEcCtD
Vemurafenib—Malnutrition—Citalopram—alcohol dependence	0.000994	0.00387	CcSEcCtD
Vemurafenib—Dysgeusia—Citalopram—alcohol dependence	0.000973	0.00379	CcSEcCtD
Vemurafenib—CYP1A2—blood—alcohol dependence	0.000973	0.00787	CbGeAlD
Vemurafenib—Asthenia—Acamprosate—alcohol dependence	0.000971	0.00378	CcSEcCtD
Vemurafenib—Back pain—Citalopram—alcohol dependence	0.000961	0.00374	CcSEcCtD
Vemurafenib—Pruritus—Acamprosate—alcohol dependence	0.000957	0.00373	CcSEcCtD
Vemurafenib—ABCC1—liver—alcohol dependence	0.000955	0.00772	CbGeAlD
Vemurafenib—Hypersensitivity—Naltrexone—alcohol dependence	0.000943	0.00367	CcSEcCtD
Vemurafenib—ABCC1—cerebellum—alcohol dependence	0.000933	0.00754	CbGeAlD
Vemurafenib—Diarrhoea—Acamprosate—alcohol dependence	0.000926	0.0036	CcSEcCtD
Vemurafenib—Asthenia—Naltrexone—alcohol dependence	0.000918	0.00358	CcSEcCtD
Vemurafenib—ALB—brain—alcohol dependence	0.000918	0.00742	CbGeAlD
Vemurafenib—Pruritus—Naltrexone—alcohol dependence	0.000905	0.00353	CcSEcCtD
Vemurafenib—Dizziness—Acamprosate—alcohol dependence	0.000895	0.00348	CcSEcCtD
Vemurafenib—Diarrhoea—Naltrexone—alcohol dependence	0.000876	0.00341	CcSEcCtD
Vemurafenib—Cough—Citalopram—alcohol dependence	0.000867	0.00338	CcSEcCtD
Vemurafenib—Vomiting—Acamprosate—alcohol dependence	0.00086	0.00335	CcSEcCtD
Vemurafenib—Rash—Acamprosate—alcohol dependence	0.000853	0.00332	CcSEcCtD
Vemurafenib—Dermatitis—Acamprosate—alcohol dependence	0.000852	0.00332	CcSEcCtD
Vemurafenib—Headache—Acamprosate—alcohol dependence	0.000847	0.0033	CcSEcCtD
Vemurafenib—Dizziness—Naltrexone—alcohol dependence	0.000846	0.0033	CcSEcCtD
Vemurafenib—Myalgia—Citalopram—alcohol dependence	0.000846	0.00329	CcSEcCtD
Vemurafenib—Arthralgia—Citalopram—alcohol dependence	0.000846	0.00329	CcSEcCtD
Vemurafenib—CYP1A2—endocrine gland—alcohol dependence	0.000844	0.00682	CbGeAlD
Vemurafenib—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.00084	0.00327	CcSEcCtD
Vemurafenib—ABCG2—testis—alcohol dependence	0.000836	0.00676	CbGeAlD
Vemurafenib—Vomiting—Naltrexone—alcohol dependence	0.000814	0.00317	CcSEcCtD
Vemurafenib—Anaphylactic shock—Citalopram—alcohol dependence	0.000811	0.00316	CcSEcCtD
Vemurafenib—Rash—Naltrexone—alcohol dependence	0.000807	0.00314	CcSEcCtD
Vemurafenib—Dermatitis—Naltrexone—alcohol dependence	0.000806	0.00314	CcSEcCtD
Vemurafenib—Infection—Citalopram—alcohol dependence	0.000806	0.00314	CcSEcCtD
Vemurafenib—Nausea—Acamprosate—alcohol dependence	0.000803	0.00313	CcSEcCtD
Vemurafenib—Headache—Naltrexone—alcohol dependence	0.000802	0.00312	CcSEcCtD
Vemurafenib—Nervous system disorder—Citalopram—alcohol dependence	0.000795	0.0031	CcSEcCtD
Vemurafenib—ABCG2—liver—alcohol dependence	0.00079	0.00639	CbGeAlD
Vemurafenib—Skin disorder—Citalopram—alcohol dependence	0.000788	0.00307	CcSEcCtD
Vemurafenib—ABCG2—cerebellum—alcohol dependence	0.000772	0.00625	CbGeAlD
Vemurafenib—CYP1A2—liver—alcohol dependence	0.000761	0.00615	CbGeAlD
Vemurafenib—Nausea—Naltrexone—alcohol dependence	0.00076	0.00296	CcSEcCtD
Vemurafenib—Hypotension—Citalopram—alcohol dependence	0.000758	0.00295	CcSEcCtD
Vemurafenib—ABCC1—brain—alcohol dependence	0.000758	0.00613	CbGeAlD
Vemurafenib—CYP3A4—digestive system—alcohol dependence	0.000739	0.00598	CbGeAlD
Vemurafenib—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.000739	0.00288	CcSEcCtD
Vemurafenib—CYP2D6—digestive system—alcohol dependence	0.000727	0.00588	CbGeAlD
Vemurafenib—Decreased appetite—Citalopram—alcohol dependence	0.000705	0.00275	CcSEcCtD
Vemurafenib—CYP3A4—blood—alcohol dependence	0.000704	0.0057	CbGeAlD
Vemurafenib—Gastrointestinal disorder—Citalopram—alcohol dependence	0.0007	0.00273	CcSEcCtD
Vemurafenib—Fatigue—Citalopram—alcohol dependence	0.000699	0.00272	CcSEcCtD
Vemurafenib—Constipation—Citalopram—alcohol dependence	0.000693	0.0027	CcSEcCtD
Vemurafenib—CYP2D6—blood—alcohol dependence	0.000693	0.0056	CbGeAlD
Vemurafenib—Body temperature increased—Citalopram—alcohol dependence	0.000641	0.0025	CcSEcCtD
Vemurafenib—ABCG2—brain—alcohol dependence	0.000627	0.00507	CbGeAlD
Vemurafenib—CYP3A4—endocrine gland—alcohol dependence	0.000611	0.00494	CbGeAlD
Vemurafenib—CYP2D6—endocrine gland—alcohol dependence	0.000601	0.00486	CbGeAlD
Vemurafenib—Hypersensitivity—Citalopram—alcohol dependence	0.000597	0.00233	CcSEcCtD
Vemurafenib—Asthenia—Citalopram—alcohol dependence	0.000582	0.00227	CcSEcCtD
Vemurafenib—Pruritus—Citalopram—alcohol dependence	0.000574	0.00223	CcSEcCtD
Vemurafenib—CYP2D6—testis—alcohol dependence	0.000573	0.00464	CbGeAlD
Vemurafenib—CYP3A4—nervous system—alcohol dependence	0.000572	0.00462	CbGeAlD
Vemurafenib—CYP2D6—nervous system—alcohol dependence	0.000562	0.00455	CbGeAlD
Vemurafenib—Diarrhoea—Citalopram—alcohol dependence	0.000555	0.00216	CcSEcCtD
Vemurafenib—CYP3A4—liver—alcohol dependence	0.000551	0.00445	CbGeAlD
Vemurafenib—CYP3A4—central nervous system—alcohol dependence	0.00055	0.00445	CbGeAlD
Vemurafenib—CYP2D6—liver—alcohol dependence	0.000542	0.00438	CbGeAlD
Vemurafenib—CYP2D6—central nervous system—alcohol dependence	0.000542	0.00438	CbGeAlD
Vemurafenib—Dizziness—Citalopram—alcohol dependence	0.000536	0.00209	CcSEcCtD
Vemurafenib—CYP2D6—cerebellum—alcohol dependence	0.000529	0.00428	CbGeAlD
Vemurafenib—Vomiting—Citalopram—alcohol dependence	0.000516	0.00201	CcSEcCtD
Vemurafenib—Rash—Citalopram—alcohol dependence	0.000511	0.00199	CcSEcCtD
Vemurafenib—Dermatitis—Citalopram—alcohol dependence	0.000511	0.00199	CcSEcCtD
Vemurafenib—Headache—Citalopram—alcohol dependence	0.000508	0.00198	CcSEcCtD
Vemurafenib—Nausea—Citalopram—alcohol dependence	0.000482	0.00188	CcSEcCtD
Vemurafenib—CYP2D6—brain—alcohol dependence	0.00043	0.00348	CbGeAlD
Vemurafenib—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000319	0.00166	CbGpPWpGaD
Vemurafenib—CYP2D6—Biological oxidations—ADH1B—alcohol dependence	0.000313	0.00163	CbGpPWpGaD
Vemurafenib—RAF1—Regulation of retinoblastoma protein—EP300—alcohol dependence	0.000303	0.00158	CbGpPWpGaD
Vemurafenib—CYP1A2—Biological oxidations—ADH7—alcohol dependence	0.000303	0.00157	CbGpPWpGaD
Vemurafenib—RAF1—Transmembrane transport of small molecules—GABRB1—alcohol dependence	0.000293	0.00152	CbGpPWpGaD
Vemurafenib—ABCC1—Transmembrane transport of small molecules—GABRB1—alcohol dependence	0.000291	0.00151	CbGpPWpGaD
Vemurafenib—CYP1A2—Biological oxidations—GGT2—alcohol dependence	0.00029	0.00151	CbGpPWpGaD
Vemurafenib—RAF1—Transmission across Chemical Synapses—MAOA—alcohol dependence	0.000289	0.0015	CbGpPWpGaD
Vemurafenib—CYP1A2—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000281	0.00146	CbGpPWpGaD
Vemurafenib—CYP3A4—Biological oxidations—ADH4—alcohol dependence	0.000275	0.00143	CbGpPWpGaD
Vemurafenib—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000273	0.00142	CbGpPWpGaD
Vemurafenib—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000272	0.00141	CbGpPWpGaD
Vemurafenib—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000268	0.00139	CbGpPWpGaD
Vemurafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—alcohol dependence	0.000268	0.00139	CbGpPWpGaD
Vemurafenib—RAF1—Neuronal System—GRIN2B—alcohol dependence	0.000267	0.00138	CbGpPWpGaD
Vemurafenib—CYP1A2—Biological oxidations—ADH1B—alcohol dependence	0.000265	0.00138	CbGpPWpGaD
Vemurafenib—ABCG2—HIF-1-alpha transcription factor network—EP300—alcohol dependence	0.000265	0.00137	CbGpPWpGaD
Vemurafenib—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000264	0.00137	CbGpPWpGaD
Vemurafenib—RAF1—Neuronal System—SLC6A3—alcohol dependence	0.000263	0.00136	CbGpPWpGaD
Vemurafenib—CYP2D6—Biological oxidations—MAOB—alcohol dependence	0.000259	0.00135	CbGpPWpGaD
Vemurafenib—ABCG2—Transmembrane transport of small molecules—GABRB1—alcohol dependence	0.000256	0.00133	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways in Glioblastoma—EP300—alcohol dependence	0.000255	0.00132	CbGpPWpGaD
Vemurafenib—RAF1—Transmembrane transport of small molecules—GABRA2—alcohol dependence	0.00025	0.0013	CbGpPWpGaD
Vemurafenib—ABCC1—Transmembrane transport of small molecules—GABRA2—alcohol dependence	0.000247	0.00128	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—OPRK1—alcohol dependence	0.000246	0.00128	CbGpPWpGaD
Vemurafenib—RAF1—Axon guidance—GRIN2B—alcohol dependence	0.000236	0.00123	CbGpPWpGaD
Vemurafenib—CYP1A2—Phase II conjugation—GGT1—alcohol dependence	0.000235	0.00122	CbGpPWpGaD
Vemurafenib—CYP3A4—Biological oxidations—ADH7—alcohol dependence	0.000233	0.00121	CbGpPWpGaD
Vemurafenib—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000231	0.0012	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—WASF2—alcohol dependence	0.000231	0.0012	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—ADH6—alcohol dependence	0.000227	0.00118	CbGpPWpGaD
Vemurafenib—BRAF—Integrated Breast Cancer Pathway—EP300—alcohol dependence	0.000226	0.00117	CbGpPWpGaD
Vemurafenib—CYP3A4—Biological oxidations—GGT2—alcohol dependence	0.000224	0.00116	CbGpPWpGaD
Vemurafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—alcohol dependence	0.000223	0.00116	CbGpPWpGaD
Vemurafenib—RAF1—Neuronal System—MAOA—alcohol dependence	0.000222	0.00115	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—WASF1—alcohol dependence	0.000222	0.00115	CbGpPWpGaD
Vemurafenib—CYP2D6—Biological oxidations—ALDH2—alcohol dependence	0.000221	0.00115	CbGpPWpGaD
Vemurafenib—CYP1A2—Biological oxidations—MAOB—alcohol dependence	0.00022	0.00114	CbGpPWpGaD
Vemurafenib—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000219	0.00114	CbGpPWpGaD
Vemurafenib—ABCG2—Transmembrane transport of small molecules—GABRA2—alcohol dependence	0.000218	0.00113	CbGpPWpGaD
Vemurafenib—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000217	0.00113	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—OPRK1—alcohol dependence	0.00021	0.00109	CbGpPWpGaD
Vemurafenib—CYP3A4—Biological oxidations—ADH1B—alcohol dependence	0.000205	0.00106	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—ADH6—alcohol dependence	0.0002	0.00104	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—ADH1A—alcohol dependence	0.000188	0.000978	CbGpPWpGaD
Vemurafenib—CYP1A2—Biological oxidations—ALDH2—alcohol dependence	0.000187	0.00097	CbGpPWpGaD
Vemurafenib—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000186	0.000965	CbGpPWpGaD
Vemurafenib—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000179	0.000927	CbGpPWpGaD
Vemurafenib—CYP2D6—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000178	0.000923	CbGpPWpGaD
Vemurafenib—CYP2D6—Biological oxidations—CYP2E1—alcohol dependence	0.000176	0.000916	CbGpPWpGaD
Vemurafenib—RAF1—TGF-beta Signaling Pathway—EP300—alcohol dependence	0.000174	0.000905	CbGpPWpGaD
Vemurafenib—CYP2D6—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000174	0.000903	CbGpPWpGaD
Vemurafenib—CYP3A4—Biological oxidations—MAOB—alcohol dependence	0.00017	0.000881	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—GRIN2B—alcohol dependence	0.000169	0.000876	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—ADH1A—alcohol dependence	0.000166	0.000861	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—OPRD1—alcohol dependence	0.000165	0.000859	CbGpPWpGaD
Vemurafenib—CYP2D6—Biological oxidations—GGT1—alcohol dependence	0.000162	0.000841	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—ADH4—alcohol dependence	0.00016	0.000832	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—PDYN—alcohol dependence	0.000159	0.000823	CbGpPWpGaD
Vemurafenib—ALB—Transmembrane transport of small molecules—GABRB1—alcohol dependence	0.000158	0.00082	CbGpPWpGaD
Vemurafenib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—alcohol dependence	0.000153	0.000792	CbGpPWpGaD
Vemurafenib—CYP1A2—Aryl Hydrocarbon Receptor—EP300—alcohol dependence	0.000153	0.000792	CbGpPWpGaD
Vemurafenib—CYP1A2—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000151	0.000782	CbGpPWpGaD
Vemurafenib—ALB—SLC-mediated transmembrane transport—SLC6A3—alcohol dependence	0.00015	0.000776	CbGpPWpGaD
Vemurafenib—CYP1A2—Biological oxidations—CYP2E1—alcohol dependence	0.000149	0.000776	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—CRHR1—alcohol dependence	0.000147	0.000765	CbGpPWpGaD
Vemurafenib—CYP1A2—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000147	0.000765	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—OPRK1—alcohol dependence	0.000145	0.000755	CbGpPWpGaD
Vemurafenib—CYP2D6—Biological oxidations—MAOA—alcohol dependence	0.000145	0.000753	CbGpPWpGaD
Vemurafenib—CYP3A4—Biological oxidations—ALDH2—alcohol dependence	0.000144	0.000749	CbGpPWpGaD
Vemurafenib—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000143	0.000745	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—OPRD1—alcohol dependence	0.000141	0.000733	CbGpPWpGaD
Vemurafenib—RAF1—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	0.000141	0.000733	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—ADH4—alcohol dependence	0.000141	0.000732	CbGpPWpGaD
Vemurafenib—ABCC1—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	0.00014	0.000727	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	0.000139	0.00072	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—CHRM2—alcohol dependence	0.000139	0.00072	CbGpPWpGaD
Vemurafenib—CYP1A2—Biological oxidations—GGT1—alcohol dependence	0.000137	0.000712	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—ADH7—alcohol dependence	0.000136	0.000707	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—PDYN—alcohol dependence	0.000135	0.000703	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—WASF2—alcohol dependence	0.000135	0.000699	CbGpPWpGaD
Vemurafenib—ALB—Transmembrane transport of small molecules—GABRA2—alcohol dependence	0.000134	0.000697	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—GGT2—alcohol dependence	0.000131	0.000678	CbGpPWpGaD
Vemurafenib—RAF1—Integrated Pancreatic Cancer Pathway—EP300—alcohol dependence	0.00013	0.000673	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—WASF1—alcohol dependence	0.000129	0.00067	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—OPRM1—alcohol dependence	0.000127	0.000661	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—WASF2—alcohol dependence	0.000126	0.000653	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—CRHR1—alcohol dependence	0.000126	0.000653	CbGpPWpGaD
Vemurafenib—BRAF—Disease—GOT2—alcohol dependence	0.000125	0.000647	CbGpPWpGaD
Vemurafenib—ALB—SLC-mediated transmembrane transport—AVP—alcohol dependence	0.000124	0.000642	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—ADH6—alcohol dependence	0.000123	0.000641	CbGpPWpGaD
Vemurafenib—ABCG2—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	0.000123	0.000639	CbGpPWpGaD
Vemurafenib—CYP1A2—Biological oxidations—MAOA—alcohol dependence	0.000123	0.000638	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—WASF1—alcohol dependence	0.000121	0.000626	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—ADH7—alcohol dependence	0.00012	0.000622	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—ADH1B—alcohol dependence	0.000119	0.00062	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—CHRM2—alcohol dependence	0.000118	0.000614	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—NPY—alcohol dependence	0.000117	0.000608	CbGpPWpGaD
Vemurafenib—RAF1—Transmembrane transport of small molecules—AVP—alcohol dependence	0.000117	0.000606	CbGpPWpGaD
Vemurafenib—CYP3A4—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000116	0.000604	CbGpPWpGaD
Vemurafenib—ABCC1—Transmembrane transport of small molecules—AVP—alcohol dependence	0.000116	0.000601	CbGpPWpGaD
Vemurafenib—CYP3A4—Biological oxidations—CYP2E1—alcohol dependence	0.000115	0.000599	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—GGT2—alcohol dependence	0.000115	0.000597	CbGpPWpGaD
Vemurafenib—CYP3A4—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000114	0.00059	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—HTR1B—alcohol dependence	0.000113	0.000587	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—CRH—alcohol dependence	0.000113	0.000587	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—OPRM1—alcohol dependence	0.000109	0.000564	CbGpPWpGaD
Vemurafenib—BRAF—Disease—GOT1—alcohol dependence	0.000108	0.000558	CbGpPWpGaD
Vemurafenib—CYP3A4—Biological oxidations—GGT1—alcohol dependence	0.000106	0.00055	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—ADH1B—alcohol dependence	0.000105	0.000546	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—ADH1A—alcohol dependence	0.000102	0.000531	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—ADH6—alcohol dependence	0.000102	0.000529	CbGpPWpGaD
Vemurafenib—ABCG2—Transmembrane transport of small molecules—AVP—alcohol dependence	0.000102	0.000529	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—NPY—alcohol dependence	0.0001	0.000519	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—MAOB—alcohol dependence	9.9e-05	0.000514	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—DRD4—alcohol dependence	9.88e-05	0.000513	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—OPRD1—alcohol dependence	9.77e-05	0.000507	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—HTR1B—alcohol dependence	9.65e-05	0.000501	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—CRH—alcohol dependence	9.65e-05	0.000501	CbGpPWpGaD
Vemurafenib—CYP3A4—Biological oxidations—MAOA—alcohol dependence	9.49e-05	0.000493	CbGpPWpGaD
Vemurafenib—CYP2D6—Biological oxidations—POMC—alcohol dependence	9.45e-05	0.00049	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—CNR1—alcohol dependence	9.43e-05	0.00049	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—PDYN—alcohol dependence	9.37e-05	0.000486	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—DRD2—alcohol dependence	9.2e-05	0.000478	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—HTR7—alcohol dependence	9.2e-05	0.000478	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—MAOB—alcohol dependence	8.71e-05	0.000452	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CRHR1—alcohol dependence	8.71e-05	0.000452	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—WASF2—alcohol dependence	8.71e-05	0.000452	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—ADH4—alcohol dependence	8.7e-05	0.000452	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—ADH6—alcohol dependence	8.64e-05	0.000448	CbGpPWpGaD
Vemurafenib—RAF1—Disease—GOT2—alcohol dependence	8.62e-05	0.000447	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—GOT2—alcohol dependence	8.55e-05	0.000444	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—ADH1A—alcohol dependence	8.45e-05	0.000439	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—DRD4—alcohol dependence	8.43e-05	0.000438	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—ALDH2—alcohol dependence	8.42e-05	0.000437	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—WASF1—alcohol dependence	8.35e-05	0.000433	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CHRM2—alcohol dependence	8.19e-05	0.000425	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	8.09e-05	0.00042	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—CNR1—alcohol dependence	8.05e-05	0.000418	CbGpPWpGaD
Vemurafenib—CYP1A2—Biological oxidations—POMC—alcohol dependence	8e-05	0.000415	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—HTR7—alcohol dependence	7.86e-05	0.000408	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—DRD2—alcohol dependence	7.86e-05	0.000408	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—AVP—alcohol dependence	7.74e-05	0.000402	CbGpPWpGaD
Vemurafenib—ALB—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	7.6e-05	0.000395	CbGpPWpGaD
Vemurafenib—ALB—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	7.53e-05	0.000391	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—OPRM1—alcohol dependence	7.52e-05	0.00039	CbGpPWpGaD
Vemurafenib—RAF1—Disease—GOT1—alcohol dependence	7.44e-05	0.000386	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—ALDH2—alcohol dependence	7.41e-05	0.000384	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—ADH7—alcohol dependence	7.4e-05	0.000384	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—GOT1—alcohol dependence	7.38e-05	0.000383	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—ADH4—alcohol dependence	7.18e-05	0.000373	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—GOT2—alcohol dependence	7.16e-05	0.000371	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—ADH1A—alcohol dependence	7.16e-05	0.000371	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—GGT2—alcohol dependence	7.09e-05	0.000368	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—NPY—alcohol dependence	6.92e-05	0.000359	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—CYP2E1—alcohol dependence	6.73e-05	0.000349	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CRH—alcohol dependence	6.68e-05	0.000347	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—HTR1B—alcohol dependence	6.68e-05	0.000347	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—ADH6—alcohol dependence	6.67e-05	0.000346	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—AVP—alcohol dependence	6.61e-05	0.000343	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—ADH1B—alcohol dependence	6.49e-05	0.000337	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—HTR2A—alcohol dependence	6.44e-05	0.000335	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—GOT2—alcohol dependence	6.3e-05	0.000327	CbGpPWpGaD
Vemurafenib—ALB—Transmembrane transport of small molecules—AVP—alcohol dependence	6.29e-05	0.000326	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—GGT1—alcohol dependence	6.18e-05	0.000321	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—GOT1—alcohol dependence	6.18e-05	0.000321	CbGpPWpGaD
Vemurafenib—CYP3A4—Biological oxidations—POMC—alcohol dependence	6.18e-05	0.000321	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—ADH7—alcohol dependence	6.11e-05	0.000317	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—ADH4—alcohol dependence	6.09e-05	0.000316	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—EP300—alcohol dependence	6.06e-05	0.000315	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—EP300—alcohol dependence	5.95e-05	0.000309	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—CYP2E1—alcohol dependence	5.92e-05	0.000307	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—GGT2—alcohol dependence	5.86e-05	0.000304	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—DRD4—alcohol dependence	5.83e-05	0.000303	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CNR1—alcohol dependence	5.57e-05	0.000289	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—MAOA—alcohol dependence	5.54e-05	0.000287	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—ADH1A—alcohol dependence	5.52e-05	0.000287	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—HTR2A—alcohol dependence	5.5e-05	0.000286	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—GOT1—alcohol dependence	5.44e-05	0.000282	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—GGT1—alcohol dependence	5.44e-05	0.000282	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—HTR7—alcohol dependence	5.44e-05	0.000282	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—DRD2—alcohol dependence	5.44e-05	0.000282	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—MAOB—alcohol dependence	5.37e-05	0.000279	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	5.37e-05	0.000279	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—EP300—alcohol dependence	5.36e-05	0.000278	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—ADH1B—alcohol dependence	5.36e-05	0.000278	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	5.27e-05	0.000273	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—ADH7—alcohol dependence	5.17e-05	0.000269	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—POMC—alcohol dependence	5.15e-05	0.000267	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—GGT2—alcohol dependence	4.96e-05	0.000257	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—MAOA—alcohol dependence	4.87e-05	0.000253	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—ADH4—alcohol dependence	4.7e-05	0.000244	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—AVP—alcohol dependence	4.58e-05	0.000237	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—ALDH2—alcohol dependence	4.57e-05	0.000237	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—ADH1B—alcohol dependence	4.54e-05	0.000236	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—MAOB—alcohol dependence	4.44e-05	0.00023	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—POMC—alcohol dependence	4.39e-05	0.000228	CbGpPWpGaD
Vemurafenib—ALB—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	4.39e-05	0.000228	CbGpPWpGaD
Vemurafenib—BRAF—Disease—EP300—alcohol dependence	4.16e-05	0.000216	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—ADH7—alcohol dependence	3.99e-05	0.000207	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—GOT2—alcohol dependence	3.89e-05	0.000202	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—GGT2—alcohol dependence	3.83e-05	0.000199	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—HTR2A—alcohol dependence	3.81e-05	0.000198	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—ALDH2—alcohol dependence	3.77e-05	0.000196	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—MAOB—alcohol dependence	3.76e-05	0.000195	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—CYP2E1—alcohol dependence	3.65e-05	0.00019	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—POMC—alcohol dependence	3.6e-05	0.000187	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—ADH1B—alcohol dependence	3.5e-05	0.000182	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—GGT1—alcohol dependence	3.35e-05	0.000174	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—GOT1—alcohol dependence	3.35e-05	0.000174	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—GOT2—alcohol dependence	3.21e-05	0.000167	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—EP300—alcohol dependence	3.2e-05	0.000166	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—ALDH2—alcohol dependence	3.2e-05	0.000166	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—POMC—alcohol dependence	3.17e-05	0.000165	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—EP300—alcohol dependence	3.12e-05	0.000162	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	3.07e-05	0.00016	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—POMC—alcohol dependence	3.04e-05	0.000158	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—CYP2E1—alcohol dependence	3.02e-05	0.000157	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—MAOA—alcohol dependence	3.01e-05	0.000156	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—EP300—alcohol dependence	2.92e-05	0.000151	CbGpPWpGaD
Vemurafenib—ALB—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	2.92e-05	0.000151	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—MAOB—alcohol dependence	2.9e-05	0.000151	CbGpPWpGaD
Vemurafenib—RAF1—Disease—EP300—alcohol dependence	2.88e-05	0.00015	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—EP300—alcohol dependence	2.85e-05	0.000148	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—GOT1—alcohol dependence	2.77e-05	0.000144	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—GGT1—alcohol dependence	2.77e-05	0.000144	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—GOT2—alcohol dependence	2.72e-05	0.000141	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—CYP2E1—alcohol dependence	2.56e-05	0.000133	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—MAOA—alcohol dependence	2.48e-05	0.000129	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—ALDH2—alcohol dependence	2.47e-05	0.000128	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—EP300—alcohol dependence	2.39e-05	0.000124	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—GOT1—alcohol dependence	2.35e-05	0.000122	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—GGT1—alcohol dependence	2.35e-05	0.000122	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—EP300—alcohol dependence	2.1e-05	0.000109	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—MAOA—alcohol dependence	2.1e-05	0.000109	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—GOT2—alcohol dependence	2.1e-05	0.000109	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	2.04e-05	0.000106	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—EP300—alcohol dependence	2.02e-05	0.000105	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—CYP2E1—alcohol dependence	1.97e-05	0.000102	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—POMC—alcohol dependence	1.96e-05	0.000102	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—GGT1—alcohol dependence	1.81e-05	9.4e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—GOT1—alcohol dependence	1.81e-05	9.4e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—MAOA—alcohol dependence	1.62e-05	8.42e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—POMC—alcohol dependence	1.62e-05	8.39e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—POMC—alcohol dependence	1.37e-05	7.11e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—EP300—alcohol dependence	1.3e-05	6.74e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—EP300—alcohol dependence	1.07e-05	5.56e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—POMC—alcohol dependence	1.06e-05	5.48e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—EP300—alcohol dependence	9.08e-06	4.71e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—EP300—alcohol dependence	7.01e-06	3.64e-05	CbGpPWpGaD
